Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Antimicrobial Agents and Chemotherapy|July 5, 2023
Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort StudyThamer A Almangour, Leen Ghonem, Dareen Alassiri, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Ceftazidime-Avibactam Versus Colistin for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections: A Multicenter Cohort StudyThamer A Almangour, Zakiyah Alkherb, Leen Ghonem, et al.
Journal of Global Antimicrobial Resistance|February 5, 2022
Ceftolozane-tazobactam vs. colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa: a multicentre cohort studyThamer A Almangour, Ahmad Aljabri, Mohammed Al Musawa, et al.
Journal of Epidemiology and Global Health|January 10, 2023
Outcome of Transplant Recipients Infected with Omicron BA.1 and BA.2: A Single-Center Retrospective Study in Saudi ArabiaAbeer N Alshukairi, Yasser Aldabbagh, Sabir A Adroub, et al.
Infection and Drug Resistance|March 20, 2026
Daptomycin Dosing Based on Adjusted Body Weight in Obese Patients versus Actual Body Weight: A Multicentre Cohort StudyThamer A Almangour, Latifa S Almosabhi, Rahaf Almojel, et al.
BMC Infectious Diseases|May 26, 2026
Beyond traditional tetracyclines: a real-world evaluation of effectiveness and safety of omadacycline therapy for complex bacterial infectionsMohammed Al Musawa, Amer El Ghali, Taylor Morrisette, et al.
Infectious Diseases and Therapy|June 6, 2025
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Microbiology Spectrum|March 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving EnterobacteralesSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2026
Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centersAshlan J Kunz Coyne, Chloe Judd, Kristen Lucas, et al.
Pageof 2